Home » Topics » Regulatory » Patents

Patents
RSS

Novel antitumor agents from Universidad Complutense

April 2, 1997

Centocor describes peptide inhibitors of selectin binding

April 2, 1997

MS&D prepares antimigraine pyrrolo-pyridine derivatives

April 2, 1997

Endothelin antagonists from SmithKline Beecham

April 2, 1997

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Hypoglycemic/hypolipidemic agents from Sankyo

April 1, 1997

Wakunaga discloses angiotensin II antagonists

April 1, 1997

Takeda reports new carbapenems

April 1, 1997

New antitumor agents from Daiichi

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...